Differences between Physostigmine- and Yohimbine-induced States Are Visualized in Canonical Space Constructed from EEG during Natural Sleep-wake Cycle in Rats

다국어 초록 (Multilingual Abstract)

Although quantitative EEG parameters, such as spectral band powers, are sensitive to centrally acting drugs in dose- and time-related manners, changes of the EEG parameters are redundant. It is desirable to reduce multiple EEG parameters to a few components that can be manageable in a real space as well as be considered as parameters representing drug effects. We calculated factor loadings from normalized values of eight relative band powers (powers of 0.5, 1.0∼2.0, 2.5∼4.0, 4.5∼5.5, 6.0∼8.0, 8.5∼12.0, 12.5∼24.5, and 25∼49.5 Hz bands expressed as ratios of the power of 0.5-49.5 Hz band) of EEG during pre-drug periods (11:00∼12:00) by factor analysis and constructed a two-dimensional canonical space (reference canonical space) by canonical correlation analysis. Eight relative band powers of EEG produced by either physostigmine or yohimbine were reduced to two canonical scores in the reference canonical space. While changes of the band powers produced by physostigmine and yohimbine were too redundant to describe the difference between two drugs, locations of two drugs in the reference canonical space represented the difference between two drug's effects on EEG. Because the distance between two locations in the canonical space (Mahalanobis distance) indicates the magnitude of difference between two different sets of EEG parameters statistically, the canonical scores and the distance may be used to quantitatively and qualitatively describe the dose-dependent and time-dependent effects and also tell similarity and dissimilarity among effects. Then, the combination of power spectral analysis and statistical analysis may help to classify actions of centrally acting drugs.

참고문헌 (Reference)

1 Fairchild MD, "The quantitative measurement of changes in EEG frequency spectra produced in the cat by sedative-hypnotics and neuroleptics" 49 : 382-390, 1980

2 John ER, "Subtyping of psychiatric patients by cluster analysis of QEEG" 4 : 321-326, 1992

3 장환수, "Role of Dopamine Receptors on Electroencephalographic Changes Produced by Repetitive Apomorphine Treatments in Rats" 대한약리학회 13 (13): 147-151, 2009

4 Hansen ES, "Quantitative electroencephalography in OCD patients treated with paroxetine" 34 : 70-74, 2003

5 Knott VJ, "Quantitative EEG in the prediction of antidepressant response to imipramine" 39 : 175-184, 1996

6 Luckhaus C, "Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study" 23 : 1148-1155, 2008

7 Bol CJ, "Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat" 294 : 347-355, 2000

8 Dimpfel W, "Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG)" 8 : 199-207, 2003

9 Parker TJ, "Pharmacokinetic-pharmacodynamic modelling in the early development phase of anti-psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats" 132 : 151-158, 2001

10 Mandema JW, "Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity" 257 : 472-478, 1991

11 Lee MG, "Pharmacodynamic interactions of diazepam and flumazenil on cortical EEG in rats" 7 : 242-248, 1999

12 John ER, "Neurometric evaluation of cognitive dysfunctions and neurological disorders in children" 21 : 239-290, 1983

13 McLachlan GJ, "Mahalanobis distance" 1999

14 van Riezen H, "Introduction and history of the use of electroencephalography in animal drug studies" 28 : 118-121, 1993

15 Itil TM, "HZI systems for EEG parametrization and classification of psychotropic drugs" 12 : 4-19, 1979

16 John ER, "Electrophysiological subtypes of psychotic states" 116 : 17-35, 2007

17 Herrmann WM, "Electroencephalography in drug research" Gustav Fischer Verlag 1982

18 Xi M, "Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig" 31 : 1043-1051, 2008

19 Ruigt GS, "Computerbased prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep" 280 : 138-153, 1993

20 Galderisi S, "Clinical applications of pharmaco-EEG in psychiatry: the prediction of response to treatment with antipsychotics" 24 (24): 85-89, 2002

21 Krijzer F, "Classification of psychotropic drugs based on pharmaco-electrocorticographic studies in vigilance-controlled rats" 28 : 122-137, 1993

22 Dimpfel W, "Classification of drugs by stereotactic recording of focal brain activity in the rat (stereo-EEG)" 12 : 188-195, 1984

23 Fairchild MD, "An application of long-term frequency analysis in measuring drugspecific alterations in the EEG of the cat" 38 : 337-348, 1975

24 Leiser SC, "Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research" Biochem Pharmacol